Cassava Sciences | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Abbott USD 25.12B 28M 2025-03
Amgen USD 538M 33.04B 2025-06
Biogen USD 146.6M 146.5M 2025-06
Cassava Sciences USD 48K 0 2024-12
Eisai JPY 282.12M 44.7B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Geron USD 636.92M 636.28M 2025-06
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Roche Holding CHF 107M 0 2024-06


Cassava Sciences Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.